Why Loblaw’s (TSX:L) Stock Price Fell 3.8% Yesterday

Loblaw’s stock price falls on rising costs, but its leading, defensive business is a good enough reason to own it in this environment.

| More on:
Supermarket aisle with empty green shopping cart

Image source: Getty Images

Loblaw’s (TSX:L) stock price has been having a pretty good 2020 so far. It is up 5.7% year to date and up 18.6% from March lows. Clearly, Loblaw stock has been a solid defensive holding through this rough period.

Yesterday, Loblaw reported first-quarter earnings that were boosted by a March demand surge. Revenue increased 10.8% and earnings surged 30%. So, why was Loblaw’s stock price down yesterday off these results?

Loblaw’s stock price falls on revenue mix changes

Breaking down Loblaw’s results, we can see some trends emerge. Firstly, much of the extraordinary revenue growth occurred in the last two weeks of March. There has been sustained increased buying since then, with less attention to price. This can be expected to continue in the short term. The longer the crisis goes on, however, the more likely we will start seeing greater economic hardship and pricing sensitivity.

Secondly, e-commerce volume increased threefold due to the pandemic. This makes total sense. Given the circumstances, Loblaw has eliminated pick-up fees and lowered delivery fees. Management is unsure how long this will last, but this is a pressure point on margins.

And thirdly, higher-margin product revenue declined significantly as part of customers’ pandemic response. Lower sales of higher-margin categories like general merchandise, apparel, and beauty products will negatively impact margins going forward.

Expect second-quarter, COVID-related costs to hit Loblaw’s stock price

Increased costs related to keeping employees and customers safe will pressure results. Increasing wages and cleaning practices, and the installation of plastic barriers and other safeguards are big investments. According to management, this increased cost structure will persist for at least the next quarter. While visibility is low, we can safely assume that this pressure may remain for the full year. The estimated incremental cost due to the pandemic will be $90 million per month.

This will have a significant negative impact on Loblaw’s earnings.

Loblaw stock is attractive due to its defensiveness

Even with these hits to Loblaw’s financials, Loblaw stock is still attractive. This is due to its involvement in the consumer staples and pharmacy businesses, which will withstand this crisis. This is also due to the fact that Loblaw is in good financial shape. In the first quarter, the company generated $1.1 billion in free cash flow. Lastly, this is due to the fact that Loblaw is Canada’s largest food retailer and leading pharmacy outlet.

Even in this more difficult environment, Loblaw can be expected to maintain its leadership positions. The company has strong private label brands and leading market share in prescriptions and front store sales at Shoppers Drug Mart. This will all continue to work to solidify the company’s value proposition and its free cash flow generation.

Foolish bottom line

Loblaw’s stock price reacted negatively to first-quarter results yesterday. The stock got hit, even though the company is seeing unprecedented, booming demand. If we lift the curtain, we see a lot of pressure on costs and margins. This has left investors with a negative reaction. Now, we have to weigh this margin pressure with other factors. At least Loblaw is open for business, and that is a comparatively good spot in today’s environment.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

More on Coronavirus

Aircraft wing plane
Coronavirus

Air Canada (TSX:AC) Stock: Ready to Take Off?

While Air Canada is handling what it can control really well, there are many worsening macro headwinds that will likely…

Read more »

rail train
Coronavirus

Bull or Bear: Why Analysts Changed Their Tune on Aecon Stock

Analysts had been champing at the bit for the construction company, but the tides have turned.

Read more »

Biotech stocks
Coronavirus

Is Bellus Health Stock Still a Buy After 30% Earnings Jump?

The biotech continues to make progress on obtaining FDA approval for its chronic-cough therapy.

Read more »

grow dividends
Coronavirus

Goodfood Stock Likely to Double in 2022!

Goodfood (TSX:FOOD) stock has had a huge rise and fall in the last few years. But at $1.85 a share,…

Read more »

grow dividends
Coronavirus

Canfor Stock Pops 5% as Sales Climb 15% YOY

Canfor (TSX:CFP) stock remained positive about its future in the global lumber market after profits climb 15% year over year.

Read more »

edit Safety First illustration
Coronavirus

2 Crash-Proof TSX Stocks I’d Buy With $5,000

These two TSX stocks have proven they can handle this economic downturn and likely will continue to be safe far…

Read more »

TSX Today
Coronavirus

What to Watch on the TSX on Tuesday, April 26

Earnings continue to come out on the TSX today, including Air Canada (TSX:AC). Meanwhile, investors may want to continue watching…

Read more »

think thought consider
Coronavirus

Should Investors Buy Goodfood Stock Ahead of Earnings?

Goodfood (TSX:FOOD) stock dropped on Wednesday ahead of the company's earnings release. And it's unclear whether there will be anything…

Read more »